PetMed Express - PETS Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" PETS shares.
View PETS analyst ratings or view top-rated stocks.

1 analysts have issued twelve-month price objectives for PetMed Express' shares. Their PETS share price forecasts range from $18.00 to $18.00. On average, they expect the company's share price to reach $18.00 in the next year. This suggests that the stock has a possible downside of 15.6%.
View analysts price targets for PETS or view top-rated stocks among Wall Street analysts.

PetMed Express' stock was trading at $17.70 on January 1st, 2023. Since then, PETS shares have increased by 20.5% and is now trading at $21.33.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, February 6th 2023.
View our PETS earnings forecast.

PetMed Express will be holding an earnings conference call on Monday, February 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13735907".

PetMed Express, Inc. (NASDAQ:PETS) posted its earnings results on Monday, November, 7th. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.27 by $0.14. The business had revenue of $65.39 million for the quarter, compared to analysts' expectations of $65 million. PetMed Express had a trailing twelve-month return on equity of 11.17% and a net margin of 5.98%.

PetMed Express declared a quarterly dividend on Monday, November 7th. Investors of record on Friday, November 18th will be paid a dividend of $0.30 per share on Wednesday, November 30th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.63%. The ex-dividend date is Thursday, November 17th.
Read our dividend analysis for PETS.

PetMed Express (NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 5.58%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 153.85%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PETS will have a dividend payout ratio of 137.93% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for PETS.

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

PetMed Express' stock is owned by a variety of institutional and retail investors. Top institutional investors include North Star Investment Management Corp. (0.25%), Inlet Private Wealth LLC (0.19%), Exchange Traded Concepts LLC (0.10%), Exchange Traded Concepts LLC (0.10%), James Investment Research Inc. (0.08%) and Yousif Capital Management LLC (0.06%). Insiders that own company stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn.
View institutional ownership trends.

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PETS stock can currently be purchased for approximately $21.33.

PetMed Express (NASDAQ:PETS) has a market capitalization of $449.64 million and generates $273.42 million in revenue each year. The company earns $21.10 million in net income (profit) each year or $0.78 on an earnings per share basis.

The company employs 219 workers across the globe.

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for the company is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at investor@petmeds.com, or via fax at 561-526-4445.